Mechanisms of microglia-specific genetic variants associated with Alzheimer's disease

Bidragets beskrivning

Alzheimer's disease (AD), the main cause of dementia world-wide, is clinically manifested as memory impairment and executive dysfunction. Most of the pathomechanistic studies in AD have so far largely concentrated on neurons, neglecting the role of other brain cells in neurodegeneration. The goal of the MgAlz project is to elucidate microglial molecular mechanisms and regulatory pathways in AD by focusing on specific AD-associated genetic variants in PLCG2 and TREM2 genes and utilizing the latest research methodologies, mouse and human-based model systems and cohorts, PET imaging, multilevel omics, endophenotype analyses, and integrative bioinformatics to advance understanding of the role of microglia in AD. This new knowledge will advance identification of novel disease mechanisms and targets to be tested as personalized medicine-based biomarkers and therapeutic targets for AD.
Visa mer

Startår

2021

Slutår

2025

Beviljade finansiering

Mikko Hiltunen Orcid -palvelun logo
492 587 €

Finansiär

Finlands Akademi

Typ av finansiering

Akademiprojekt

Övriga uppgifter

Finansieringsbeslutets nummer

338182

Vetenskapsområden

Neurovetenskaper

Forskningsområden

Molekyyli- ja solutason neurotiede

Identifierade teman

brain, neuroscience